Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community Post date 17 November 2022 ← Angiotensin receptor blockers for the treatment of covid-19 → Accurate surveillance of maternal deaths is an international priority